An LC Ion-Pairing Method for the Determination of Fe(II) in Ferrous Bisglycinate Pharmaceutical Formulation

被引:6
作者
Ceni, Danieli Catia [1 ]
Martins, Laura Alegria [1 ]
Pereira, Andrea Garcia [1 ]
Froeehlich, Pedro Eduardo [1 ]
Bergold, Ana Maria [1 ]
机构
[1] Univ Fed Rio Grande do Sul, Programa Posgrad Ciencias Farmaceut, Fac Farm, BR-90610000 Porto Alegre, RS, Brazil
关键词
Column liquid chromatography; Ion-pairing liquid chromatography; Validation; Ferrous bisglycinate; 4-(2-Pyridylazo) resorcinol; PERFORMANCE LIQUID-CHROMATOGRAPHY; BIS-GLYCINE CHELATE; IRON BIOAVAILABILITY; DEFICIENCY; COMPLEXES; INFANTS; HUMANS; WATER;
D O I
10.1365/s10337-009-1000-8
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A reversed-phase ion-pairing liquid chromatographic method was developed and validated for the assay of Fe(II) in ferrous bisglycinate (Fe-bis-gly) capsules using 4-(2-pyridylazo) resorcinol reagent. The analysis was carried out using a Gemini RP-18 (150 mm x 4.6 mm I.D., particle size 5 mu m) analytical column; the mobile phase consisted of a mixture of acetonitrile-water (28:72 v/v) containing 1 mM tetrabutylammonium hydrogensulfate and 1% phosphate buffer (pH 8.0). The flow rate was 1.0 mL min(-1) and the detection was achieved with a photodiode array (PDA) detector at 706 nm. The specificity of the method was proved using stress conditions and evaluated using a PDA detector. The data validation showed that the method is specific, fast, accurate, and reproducible for the determination of Fe-bis-gly in dosage form. The response was linear over a range of 1.0-2.6 mu g mL(-1) (r = 0.9999). The accuracy of the method ranged from 98.02 to 102.75%. The RSD values for intra- and inter-day precision studies were below 1.3 and 1.1%, respectively. There was no interference of the excipients on the determination of the active pharmaceutical ingredient.
引用
收藏
页码:189 / 194
页数:6
相关论文
共 36 条
[1]  
Allen LH, 2000, AM J CLIN NUTR, V71, P1485
[2]   Advantages and limitations of iron amino acid chelates as iron fortificants [J].
Allen, LH .
NUTRITION REVIEWS, 2002, 60 (07) :S18-S21
[3]  
[Anonymous], 2007, HPLC PHARM SCI, DOI DOI 10.1002/0470087951
[4]  
[Anonymous], 2008, US PHARMACOPOEIA
[5]  
Ashmead H, 1985, INTESTINAL ABSORPTIO, P113
[6]  
BAYNES RD, 1990, ANNU REV NUTR, V10, P133, DOI [10.1146/annurev.nu.10.070190.001025, 10.1146/annurev.nutr.10.1.133]
[7]  
BEARD JL, 1997, HDB NUTR ESSENTIAL E, P334
[8]  
Bovell-Benjamin AC, 2000, AM J CLIN NUTR, V71, P1563
[9]  
Davidsson L, 2000, AM J CLIN NUTR, V71, P1597
[10]   IRON STATUS, IMMUNE CAPACITY AND RESISTANCE TO INFECTIONS [J].
DHUR, A ;
GALAN, P ;
HERCBERG, S .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY, 1989, 94 (01) :11-19